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Introduction 
Sickle cell parvovirus B19 transient 
aplastic crisis is a relatively common 
occurrence that can require hospitalization 
with a multi-modality treatment plan 
including a complete exchange transfusion. 
We report a case of sickle cell parvovirus 
B19 transient aplastic crisis that required 
multiple complete exchange transfusions. 
 
Case Report 
A 31-year-old, African-American 
woman presented to the emergency 
department after a two-week history of 
increasing generalized pain, with particular 
emphasis in the legs bilaterally, left arm, and 
chest. The pain was aggravated by increased 
movement, but continued while at rest.  She 
had been vaccinated against tetanus, and 
against streptococcus pneumonia  with 
Pneumococcal Vaccine Polyvalent 
(Pneumovax®), but not for meningitis.  
A review of systems was positive for 
dehydration, decreased appetite, and 
subjective fevers for three days. Her past 
medical history included sickle cell 
hemoglobinopathy, thrombosis secondary to 
a peripherally inserted central catheter line, 
laparoscopic cholecystectomy, and a 
caesarean section. She had a history of 
smoking and drinking alcohol. She was 
taking acetaminophen/oxycodone and folic 
acid.   
 
 
 
The patient was mildly obese. She was 
well-nourished and well-developed, but was 
in distress from her pain.  She was tearful.  
Her vital signs were abnormal for 
respirations of 24 breaths per minute and a 
blood pressure of 146/86 mmHg.  She had 
dry mucous membranes of the oral and 
conjunctival mucosa. A midline caesarean 
scar had no evidence of erythema or 
dehiscence. There was no evidence of 
hepatosplenomegally.  She had eczema of 
the right calf. Her sternum was tender to 
palpation. Initial laboratory data showed a 
white blood cell count of 35.2 X 10³ 
cells/mm³ with no left shift, a hemoglobin of 
6.9 gm/dl, a mean corpuscular volume of 
98.6 fL, with platelets of 1337 X 10³/mm³. 
A blood smear showed target cells, 
schistocytes, and ovalocytes. Additional labs 
showed a reticulocyte count of 2.5%.  
A chest x-ray revealed patchy infiltrates 
in both lower lobes. A two-dimensional 
echocardiogram revealed a pulmonary 
arterial pressure of 50-55 mmHg. A brain 
natriuretic peptide showed results of 1185 
pgmol/liter. Liver function tests revealed a 
maximum alanine aminotransferase of 1736 
units/liter and a maximum aspartate 
aminotransferase of 2184 units/liter.  Lactate 
dehydrogenase tests reached a maximum of 
4273 units/liter.  Direct Coombs test and 
cold   agglutinins   tests   were   negative.   A 
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hemoglobin electrophoresis yielded hemo-
globin S 53.7% and hemoglobin C 46.3%. 
Blood cultures were negative. A 
streptococcus pneumonia urine antigen was 
negative.  
A titer for parvovirus B-19 revealed an 
IgM of 10.40 mg/dl and an IgG of 4.75 
mg/dl. Sickle cell SC aplastic crises with 
parvovirus B-19 Infection was diagnosed.  
The patient was placed on three liters of 
oxygen.  She was given packed red blood 
cells, but they did not normalize her anemia. 
She initially was given IV antibiotics, fluids, 
and pain medications. Antibiotics were 
discontinued after a 10-day regimen. She 
was given one complete exchange 
transfusion to remove the sickled cells, then 
received a hemoglobin electrophoresis 
which revealed that her erythrocytes were 
still sickling (see Figure 1a). Another 
complete exchange transfusion was 
performed and another hemoglobin 
electrophoresis which then indicated 
resolution (see Figure 1b). Supportive 
therapy was given. During her hospital stay, 
she developed acute renal failure which 
resolved. She was discharged on pain 
medications with plans to improve hydration 
habits.
 
 
               (a)                                                            (b) 
 
Figure 1.  (a) The first hemoglobin electrophoresis illustrates that anemia was 
not treated adequately with the exchange transfusion, most likely due to the 
parvovirus.  (b) Another exchange transfusion was necessary for resolution.
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Discussion 
Sickle cell SC is a disorder of 
hemoglobin that leads to polymerization of 
hemoglobin S in erythrocytes causing cell 
sickling.1 The hemoglobin C gene is one-
fourth as common as the hemoglobin S 
gene, which is around 8% of the African- 
American population.2,3   
Parvovirus B-19 is a virus that is directly 
toxic to human erythroid precursor cells.  
More than seventy percent of adults have 
measurable parvovirus B-19-specific IgG 
antibodies.4 Sickle cell anemia commonly 
presents as recurrent painful crises. 
Intermittent bouts of sickling will cause 
vasoocclusion in connective and musculo-
skeletal tissue causing a painful ischemia.  
Most painful crises will present with 
acute pain, tenderness, fever, tachycardia, 
and anxiety.  When these infarctions occur 
in the pulmonary vasculature, it can cause 
acute chest syndrome, which is a medical 
emergency.  It can lead to pulmonary 
hypertension which causes a secondary right 
sided heart failure.5  
Sickle cell anemia aplastic crises can 
occur when a parvovirus B19 strain infects 
the host.  The sickle cell anemia in crises is 
exacerbated by a loss in erythropoiesis due 
to the B19 toxicity to erythroid precursors. 
Labs will show abrupt decreases in 
hemoglobin without a compensatory 
reticulocytosis.      Definitive   diagnosis   of 
Sickle cell SC hemoglobinopathy is 
determined by hemoglobin electrophoresis.  
Sickle cell hemoglobinopathies are 
suspected in a history of hemolytic anemia, 
as well as a characteristic sickling seen on a 
blood smear.5 The practical choice for 
diagnosing immunocompetent individuals 
with acute parvovirus B-19 infections is 
serum IgM and IgG antibodies or PCR. 
Additionally, decreased or lower than 
expected reticulocyte counts might be 
noted.6  
 
 
Treatment of a sickle cell aplastic crisis 
focuses on supportive care, identifying the 
problem, and treating the patient’s acute 
problems in a timely manner. The main 
treatments include giving blood transfusions 
until the patient’s immune system has 
cleared the virus, and reticulocytes and red 
blood cell function have returned.  In severe 
and chronic cases, IgG infusions might be 
needed.  
In a longitudinal study of 308 patients 
with hemoglobin SS, 91 out of 114 (80%) 
who were infected with B19 developed a 
transient aplastic crisis.7 Another study in 
633 children with sickle cell disease 
indicated that 68 parvovirus B19 aplastic 
crises occurred over a five-year period.8  
Prevention of parvovirus B19 infection 
is best achieved by using good infection 
control practices. A vaccine given to 24 
seronegative adults in a series of three doses 
over six months was highly immunogenic.7,9 
Prevention of sickle cell crisis involves 
lifestyle changes and planning ahead. 
Hydration is important to maintain 
erythrocytic volume. Staying away from hot 
or cold environments or stressful situations 
also can prevent recurrence.  
Antibiotic prophylaxis in splenec-
tomized patients prior to procedures or 
dental work also might prevent recurrence as 
well as pneumococcal and meningitis 
vaccines. Hydroxeurea also will help by 
inducing hemoglobin F production and 
decrease the amount of time that 
hemoglobin is in the deoxygenated form 
(tense) form.5  
The need for two complete exchange 
transfusions is unusual in that one complete 
exchange transfusion typically replaces the 
sickling erythrocytes and resolves such a 
crisis. Although there have been cases of 
multiple partial exchange transfusions,10 no 
other  case reports  are known describing the 
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need for more than one complete exchange 
transfusion in a sickling crisis with acute 
chest syndrome.  Therefore, our case 
indicates that multiple complete exchange 
transfusions can be warranted in such cases 
of sickle cell crisis.  
 
Conclusion 
Because sickle cell disease is a common 
condition in certain populations in the US 
and the very high existence of parvovirus 
B19 exposures in the general population, 
one must always carry a high suspicion for 
sickle cell disease parvovirus B19 aplastic 
anemia in sickle cell patients presenting with 
a crisis. The acute treatment usually is 
hospitalization with hydration, symptom 
management, and in serious cases, the 
possibility of more than one complete 
exchange transfusion. 
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